Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synergy Pharmaceuticals Inc.

www.synergypharma.com

Latest From Synergy Pharmaceuticals Inc.

'Game-Changer' For Ardelyx As Tenapanor Phase III Is A Hit In IBS-C

Positive data for its irritable bowel syndrome therapy put Ardelyx in a better position for partnering and set it up for a filing next year.

Clinical Trials Research & Development

Finance Watch: Lilly Cuts 3,500 Jobs Globally To Drive Growth

Lilly will save $500m annually starting in 2018 after $1.2bn in layoff-related costs to reinvest in new products. Also, Cytori halves its headcount; VC OrbiMed closed a $551m Asia fund; and Insmed capitalizes on positive data.

Financing Business Strategies

Tymlos Inclusion Stands Out As Express Scripts Reveals 2018 Formulary

Radius Health's pricing and reimbursement strategy has been successful, at least with Express Scripts, which included its bone-builder Tymlos on a 2018 formulary that excludes several brand-name drugs.

Pharmacy Benefit Management Market Access

Appointments: Tiziana, Ergomed, Kymab, Crescendo, Ablynx, Axcella and Alexion.

This week's roundup includes CEO appointments by Tiziana and Ergomed and executive appointments by Crescendo Biologics, Ablynx, Alexion and Axcella. In addition to this, Oxford BioTherapeutics and Kymab have announced board appointments.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synergy Pharmaceuticals Inc.
  • Senior Management
  • Gary S Jacob, PhD, CEO
    Gary G Gemignani, EVP, CFO
    Patrick H Griggin, MD, EVP, CMO
    Marino Garcia, EVP, Chief Strategy Officer
    Troy Hamilton, EVP, Chief Commercial Officer
  • Contact Info
  • Synergy Pharmaceuticals Inc.
    Phone: (212) 297-0020
    420 Lexington Ave., Ste. 2012
    New York, NY 10170
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register